Genetic Variants and Perioperative Morbidity and Mortality
Launched by INSEL GRUPPE AG, UNIVERSITY HOSPITAL BERN · Apr 24, 2014
Trial Information
Current as of November 14, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how different genetic factors might affect patients' health during and after surgery. Researchers want to understand if a patient's genetic background, along with other factors like their age and the type of surgery they are having, can influence the chances of experiencing complications, such as heart problems or allergic reactions, during and after the procedure.
To participate in this trial, you need to be at least 18 years old and scheduled for surgery. You will also need to give your written consent to join the study. Participants can expect to provide information about their health and medical history, and researchers will monitor them before, during, and after the surgery to see how they respond. This trial is currently looking for volunteers, and it's important to note that those with cognitive impairments are not eligible to participate. Your involvement could help improve understanding of how genetics impact surgical outcomes for future patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 18 years and older
- • Written informed consent
- • Scheduled surgery
- • Exclusion Criteria
- • No informed consent
- • Cognitive impairment
About Insel Gruppe Ag, University Hospital Bern
Insel Gruppe AG, the umbrella organization for the University Hospital Bern, is a leading healthcare provider in Switzerland, renowned for its commitment to advancing medical research and patient care. As a key player in clinical trials, Insel Gruppe AG integrates cutting-edge scientific inquiry with clinical excellence, facilitating innovative studies that span a wide range of medical disciplines. The institution prioritizes collaboration with academic partners and industry stakeholders to enhance the understanding of diseases and develop effective treatment options, ultimately aiming to improve patient outcomes and contribute to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bern, Switzerland
Patients applied
Trial Officials
Frank Stüber, Prof. MD
Study Chair
Department of Anaestheisolpogy + Pain Medicine, Inselspital, University of Bern
Ulrike M Stamer, MD
Principal Investigator
Department of Anaesthesiology and Pain Medicine, Inselspital, University of Bern
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials